BLOG

companyweek

CEO Glenn Mattes, VP of Product Development and Manufacturing Dr. John Koleng, and their team are disrupting traditional pharmaceutical development and manufacturing with exciting new technology.

Mattes says there isn’t an official founding date for TFF Pharmaceuticals (NASDAQ TFFP) as the company sprung from another Austin-based organization known as Lung Therapeutics circa 2017.